-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
RAPT Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
- RAPT Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$19.8M, a 41.7% increase year-over-year.
- RAPT Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$115M, a 2.89% increase year-over-year.
- RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$127M, a 48.1% decline from 2022.
- RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$85.8M, a 24% decline from 2021.
- RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$69.2M, a 30.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)